[Analysis of clinical characteristics of hypoxic hepatitis in children]

Huabo Cai1, Baoxing Huang, Zhongsheng Zhu

  • 1Department of Gastroenterology, Shenzhen Children's Hospital, Shenzhen 518038, China.

Insights

Hypoxic hepatitis (HH) in children is primarily caused by severe conditions like heart failure and shock. Laboratory tests show a significant rise in liver enzymes, which normalize once the underlying illness is treated.

Area of Science:

  • Pediatric Hepatology
  • Critical Care Medicine
  • Pediatric Gastroenterology

Background:

  • Hypoxic hepatitis (HH) is a form of liver injury resulting from insufficient oxygen supply to the liver.
  • Understanding the causes and clinical presentation of HH in children is crucial for timely diagnosis and management.

Purpose of the Study:

  • To investigate the etiological factors and clinical characteristics of hypoxic hepatitis in a pediatric population.
  • To identify the key laboratory findings associated with HH in children.

Main Methods:

  • Retrospective review of clinical data from 7 pediatric patients diagnosed with HH.
  • Analysis of patient demographics, primary diagnoses, laboratory results, and outcomes.

Main Results:

  • HH occurred in 0.32% of pediatric intensive care unit patients, with primary causes including respiratory failure and cardiac shock from severe hand-foot-and-mouth disease and fulminant myocarditis.
  • All patients exhibited significantly elevated alanine aminotransferase (ALT) levels (≥20 times the upper limit of normal), with rapid normalization after treatment of the primary condition.
  • No viral hepatitis markers (Hepatitis B, C, Epstein-Barr, Cytomegalovirus) were detected.

Conclusions:

  • Severe conditions such as heart failure, hypoxemia, and shock are the primary drivers of HH in children.
  • A marked elevation in ALT, aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) is characteristic of HH and typically resolves with treatment of the underlying disease.
  • Reversible changes in blood urea nitrogen (BUN) or creatine kinase (CK) may also be observed in some cases.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
327
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.5K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
693
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
458